AbCellera Biologics Inc.
ABCL
$10.97
$0.625.94%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.35% | -16.61% | -14.67% | -22.93% | -17.49% |
| Total Receivables | -37.78% | -8.60% | 66.50% | 152.01% | 126.53% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.95% | 39.28% | 12.10% | 31.28% | 25.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | -8.48% | -13.12% | -3.08% | -6.43% | -3.81% |
|
|
|||||
| Total Current Assets | -8.48% | -13.12% | -3.08% | -6.43% | -3.81% |
| Net Property, Plant & Equipment | -1.73% | 21.81% | 25.72% | 29.01% | 32.97% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -9.27% | -9.06% | -8.86% | -25.21% | -53.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -37.86% | -40.49% | -69.32% | -60.46% | -28.37% |
| Total Assets | -6.74% | -2.76% | -0.26% | -2.64% | -0.74% |
|
|
|||||
| Total Accounts Payable | -62.21% | -36.57% | -26.56% | -8.68% | 20.52% |
| Total Accrued Expenses | 22.38% | 23.19% | 28.42% | 20.73% | 13.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.79% | 26.57% | 25.84% | 0.80% | -12.62% |
| Total Finance Division Other Current Liabilities | 16.78% | -51.99% | -23.09% | -26.82% | -25.75% |
| Total Other Current Liabilities | 16.78% | -51.99% | -23.09% | -26.82% | -25.75% |
| Total Current Liabilities | -20.64% | -37.27% | -16.06% | -13.53% | -4.77% |
|
|
|||||
| Total Current Liabilities | -20.64% | -37.27% | -16.06% | -13.53% | -4.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.27% | 112.48% | 126.20% | 106.80% | 106.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.73% | 2.63% | 12.70% | 10.19% | 15.85% |
| Total Liabilities | 4.20% | 14.88% | 28.11% | 24.54% | 31.00% |
|
|
|||||
| Common Stock & APIC | 5.56% | 5.68% | 6.05% | 6.37% | 6.85% |
| Retained Earnings | -450.10% | -201.88% | -125.21% | -113.59% | -81.91% |
| Treasury Stock & Other | -18.63% | 65.43% | 3.29% | -118.99% | -28.17% |
| Total Common Equity | -11.03% | -8.30% | -8.44% | -10.58% | -9.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.03% | -8.30% | -8.44% | -10.58% | -9.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.03% | -8.30% | -8.44% | -10.58% | -9.35% |
|
|
|||||